SCHEMBL31322155

SCHEMBL31322155

Oc1ccc(Oc2cc(O)cc(C=Cc3cc(O)cc(Oc4ccc(O)cc4)c3)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.61
CYP1A1 P04798 5/20 0.61
CYP1B1 Q16678 4/20 0.61
TTR P02766 3/20 0.61
ALOX5 P09917 3/20 0.61
MEN1 O00255 5/20 0.59
KMT2A Q03164 5/20 0.59
KDM4E B2RXH2 5/20 0.59
MAPT P10636 4/20 0.59
CYP1A2 P05177 3/20 0.59
ALDH1A1 P00352 3/20 0.59
LMNA P02545 3/20 0.59
TP53 P04637 3/20 0.59
CYP3A4 P08684 3/20 0.59
HPGD P15428 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
HSD17B10 Q99714 3/20 0.59
PTGS1 P23219 3/20 0.59
LTA4H P09960 3/20 0.59
CA12 O43570 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2513436 0.87 CYP1A1 (0.65) PTGS2CYP1A1CYP1B1TTRALOX5
SCHEMBL2513437 0.87 CYP1A1 (0.65) PTGS2CYP1A1CYP1B1TTRALOX5
SCHEMBL2516448 0.85 KDM4E (0.62) PTGS2CYP1A1CYP1B1TTRALOX5
SCHEMBL2516451 0.85 KDM4E (0.62) PTGS2CYP1A1CYP1B1TTRALOX5
SCHEMBL31322129 0.85 MEN1 (0.51) PTGS2CYP1A1CYP1B1TTRALOX5
SCHEMBL5890304 0.84 MEN1 (0.74) PTGS2CYP1A1CYP1B1TTRALOX5
SCHEMBL28524463 0.83 PTGS1 (0.71) PTGS2CYP1A1CYP1B1TTRALOX5
SCHEMBL2521181 0.81 CYP1A1 (0.61) PTGS2CYP1A1CYP1B1TTRALOX5
SCHEMBL2521178 0.81 CYP1A1 (0.61) PTGS2CYP1A1CYP1B1TTRALOX5
SCHEMBL16551547 0.79 MEN1 (0.82) MEN1KMT2AKDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4483866-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CANCER Makrolife Biotech GmbH (DE) 2025-01-01 EP claimed
EP-4483866-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CANCER Makrolife Biotech GmbH (DE) 2025-01-01 EP disclosed